Evolve Private Wealth LLC bought a new stake in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) during the 2nd quarter, Holdings Channel.com reports. The fund bought 2,296 shares of the semiconductor company’s stock, valued at approximately $1,024,000.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Vanguard Group Inc. lifted its position in shares of Synopsys by 1.6% during the fourth quarter. Vanguard Group Inc. now owns 18,464,862 shares of the semiconductor company’s stock valued at $8,673,315,000 after buying an additional 283,677 shares during the last quarter. BlackRock Inc. acquired a new stake in Synopsys in the second quarter valued at approximately $7,228,099,000. State Street Corp increased its position in shares of Synopsys by 0.3% during the fourth quarter. State Street Corp now owns 8,788,890 shares of the semiconductor company’s stock worth $4,128,317,000 after purchasing an additional 28,532 shares in the last quarter. Morgan Stanley grew its stake in Synopsys by 2.5% during the 4th quarter. Morgan Stanley now owns 4,573,980 shares of the semiconductor company’s stock worth $2,148,491,000 after buying an additional 109,917 shares during the last quarter. Finally, Geode Capital Management LLC boosted its holdings in Synopsys by 1.3% in the fourth quarter. Geode Capital Management LLC now owns 4,310,846 shares of the semiconductor company’s stock worth $2,017,256,000 after acquiring an additional 54,329 shares in the last quarter. Hedge funds and other institutional investors own 85.47% of the company’s stock.
Analyst Ratings Changes
Several equities analysts have recently issued reports on SNPS shares. Stifel Nicolaus upped their price objective on shares of Synopsys from $550.00 to $600.00 and gave the company a “buy” rating in a report on Thursday, May 28th. Weiss Ratings reissued a “hold (c-)” rating on shares of Synopsys in a report on Monday, June 8th. Piper Sandler upgraded Synopsys from a “neutral” rating to an “overweight” rating and boosted their price target for the company from $450.00 to $550.00 in a research note on Tuesday, June 23rd. Zacks Research upgraded Synopsys from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, June 30th. Finally, Rosenblatt Securities increased their price objective on shares of Synopsys from $530.00 to $575.00 and gave the stock a “buy” rating in a research note on Tuesday, May 26th. One investment analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, Synopsys currently has a consensus rating of “Moderate Buy” and an average price target of $563.59.
Synopsys Stock Performance
SNPS stock opened at $397.87 on Monday. The company has a quick ratio of 1.32, a current ratio of 1.43 and a debt-to-equity ratio of 0.33. Synopsys, Inc. has a 52-week low of $366.00 and a 52-week high of $615.79. The company’s 50-day simple moving average is $419.73 and its 200-day simple moving average is $440.09. The firm has a market cap of $76.18 billion, a P/E ratio of 92.10, a PEG ratio of 2.34 and a beta of 1.23.
Synopsys (NASDAQ:SNPS – Get Free Report) last released its quarterly earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share for the quarter, topping analysts’ consensus estimates of $3.15 by $0.20. The company had revenue of $2.28 billion during the quarter, compared to analysts’ expectations of $2.25 billion. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.Synopsys’s quarterly revenue was up 41.9% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $3.67 EPS. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. As a group, equities analysts forecast that Synopsys, Inc. will post 10.64 EPS for the current fiscal year.
Insider Transactions at Synopsys
In other news, CEO Sassine Ghazi sold 14,603 shares of the firm’s stock in a transaction that occurred on Monday, June 15th. The stock was sold at an average price of $458.96, for a total value of $6,702,192.88. Following the transaction, the chief executive officer owned 75,020 shares in the company, valued at $34,431,179.20. This trade represents a 16.29% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Shelagh Glaser sold 3,394 shares of Synopsys stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $450.02, for a total value of $1,527,367.88. Following the completion of the sale, the chief financial officer directly owned 14,358 shares in the company, valued at $6,461,387.16. This represents a 19.12% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.56% of the stock is owned by insiders.
Synopsys Company Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Featured Stories
- Five stocks we like better than Synopsys
- VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You?
- 3 Closed-End Funds to Maximize Dividend Payments
- Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy?
- $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
